ABBOTT LABORATORIES — Director's Dealing 2012

Feb 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-02-17

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-17	Common shares without par value	A	167600	—	Acquired	1328116	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-17	Option (right to buy)	$56.26	A	302500	Acquired	2022-02-16	Common shares (302500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	23439	Indirect
Common shares without par value	6927	Indirect
Common shares without par value	6836	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 16, 2012.

F3: The reporting person disclaims beneficial ownership of all securities held by his sons.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 100,834 on 02/17/2013, 100,833 on 02/17/2014, and 100,833 on 02/17/2015.